(a) whether the Government have recently revised the prices of
several formulations, as recommended by the National
Pharmaceutical Pricing Authority (NPPA) ;
(b) if so, the criteria adopted by the NPPA to revise the prices of
formulations ;
(c) whether the NPPA have recommended revision of the formulation
prices keeping in view the interests of the industry ; and
(d) if so, the facts thereof and the corrective measures the Government
propose to take in this regard ?